Adjuvant Therapy of Nivolumab Combined with Ipilimumab Versus Nivolumab Alone in Patients with Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)

- Weber, Jeffrey S., Schadendorf, Dirk, Ascierto, Paolo A., Sandhu, Shahneen, Eigentler, Thomas, Gutzmer, Ralf, Hassel, Jessica C., Robert, Caroline, Carlino, Matteo S., Di Giacomo, Anna Maria, Butler, Marcus O., Muñoz-Couselo, Eva, Del Vecchio, Michele, Brown, Michael P., Rutkowski, P, Haydon, A, Grob, J-J, Schachter, J, Queirolo, P, de la Cruz-Merino, L, van der Westhuizen, Andre, Menzies, AM, Re, S, Larkin, James, Bas, T, de Pril, V, Braverman, J, Tenney, DJ, Tang, H, Long, GV, Atkinson, Victoria, Schenker, Michael, Pigozzo, Jacopo, Gogas, Helen, Dalle, Stéphane, Meyer, Nicolas

It is not all about the alpha: elevated expression of p53β variants is associated with lower probability of survival in a retrospective melanoma cohort

- Groen, Kira, Steffens Reinhardt, Luiza, Bourdon, Jean-Christophe, Avery-Kiejda, Kelly A.

Confocal microscopy, dermoscopy, and histopathology features of atypical intraepidermal melanocytic proliferations associated with evolution to melanoma in situ

- Rocha, Lilian K. F. L., Vilain, Ricardo E., Scolyer, Richard A., Lo, Serigne N., Drummond, Martin, Star, Phoebe, Fogarty, Gerald B., Hong, Angela M., Guitera, Pascale

Expression of NGF/proNGF and Their Receptors TrkA, p75^NTR and Sortilin in Melanoma

- Marsland, Mark, Dowdell, Amiee, Jiang, Chen Chen, Wilmott, James S., Scolyer, Richard A., Zhang, Xu Dong, Hondermarck, Hubert, Faulkner, Sam

Melanoma: An immunotherapy journey from bench to bedside

- Navani, Vishal, Graves, Moria C., Mandaliya, Hiren, Hong, Martin, van der Westhuizen, Andre, Martin, Jennifer, Bowden, Nikola A.

Mesoporous silica nanoparticles with 3D porous structures for biomedical applications

- Trinh, Hoang Trung

Repurposing azacitidine and carboplatin to prime immune checkpoint blockade-resistant melanoma for anti-PD-L1 re-challenge

- van der Westhuizen, Andre, Lyle, Megan, Vilain, Ricardo E., Bowden, Nikola A., Graves, Moira C., Zhu, Xiaoqiang, Wong, Jason W. H., Cornall, Kerrie, Ren, Shu, Pugliese, Leanna, Levy, Richard, Majid, Adeeb

Identification of the NR2C subtype of the N-Methyl-D-Aspartate Receptor (NMDAR) as a potential molecular target for melanoma treatment

- Tabatabaee, Hessam

Silica-based nanomaterials as drug delivery tools for skin cancer (melanoma) treatment

- Trinh, Hoang Trung, Mohanan, Shan, Radhakrishnan, Deepika, Tiburcius, Steffi, Yang, Jae-Hun, Verrills, Nicole M., Karakoti, Ajay, Vinu, Ajayan

Constitutional variants in POT1, TERF2IP, and ACDgenes in patients with melanoma in the Polish population

- Malińska, Karolina, Deptula, Jakub, Cybulski, Cezary, Kram, Andrzej, Boer, Magdalena, Kiedrowicz, Magdalena, Lubiński, Jan, Dębniak, Tadeusz, Rogoża-Janiszewska, Emilia, Górski, Bohdan, Scott, Rodney, Rudnicka, Helena, Kashyap, Aniruddh, Domagala, Pawel, Hybiak, Jolanta, Masojć, Bartlomiej

Cylindromatosis is required for survival of a subset of melanoma cells

- La, Ting, Jin, Lei, Teng, Liu, Liu, Xiao Ying, Song, Ze Hua, Farrelly, Margaret, Feng, Yu Chen, Yan, Xu Guang, Zhang, Yuan Yuan, Thorne, Rick F., Zhang, Xu Dong

A systematic review and meta-analysis of locoregional treatments for in-transit melanoma

- Read, Tavis, Lonne, Michael, Sparks, David S., David, Michael, Wagels, Michael, Schaider, Helmut, Soyer, H. Peter, Smithers, B. Mark

Actin crosslinking protein α-actinin-4 (ACTN4) regulates receptor-interacting serine/threonine-protein kinase 1 (RIPK1) in melanoma

- Zhang, Yuanyuan

Founder mutations for early onset melanoma as revealed by whole exome sequencing suggests that this is not associated with the increasing incidence of melanoma in Poland

- Debniak, Tadeusz, Scott, Rodney J., Kashyap, Amiruddh, Lener, Marcin R., Malinska, Karolina, Rogoza, Emilia, Murawa, David, Rudnicka, Helena, Deptula, Jakub, Lubinski, Jan, Lea, Rodney A., Górski, Bohdan, Masojc, Bartlomiej, Cybulski, Cezary, Kram, Andrzej, Maleszka, Romuald, Gromowski, Tomasz, Paszkowska-Szczur, Katarzyna

MC1R CpG island regulates MC1R expression and is methylated in a subset of melanoma tumours

- Budden, Timothy, Bowden, Nikola A.

Monitoring patient response to pembrolizumab with peripheral blood exhaustion marker profiles

- Graves, Moira, CelliMarchett, Giovana, van Zyl, Belinda, Tang, Denise, Vilain, Ricardo E., van der Westhuizen, Andre, Bowden, Nikola A.

ACTN4 regulates the stability of RIPK1 in melanoma

- Zhang, Yuan Yuan, Tabataba, Hessam, Liu, Xiao Ying, Wang, Jia Yu, Yan, Xu Guang, Farrelly, Margaret, Jiang, Chen Chen, Guo, Su Tang, Liu, Tao, Kao, Hung-Ying, Thorne, Rick F., Zhang, Xu Dong, Jin, Lei

Anti-PD-1-induced high-grade hepatitis associated with corticosteroid-resistant T cells: a case report

- McGuire, Helen M., Shklovskaya, Elena, Edwards, Jarem, Trevillian, Paul R., McCaughan, Geoffrey W., Bertolino, Patrick, McKenzie, Catriona, Gourlay, Ralph, Gallagher, Stuart J., Fazekas de St. Groth, Barbara, Hersey, Peter

BRCA1/2 mutations are not a common cause of malignant melanoma in the Polish population

- Debniak, Tadeusz, Scott, Rodney J., Malinska, Karolina, Kiedrowicz, Magdalena, Rogoza-Janiszewska, Emilia, Rudnicka, Helena, Deptula, Jakub, Domagala, Paweo, Kluzniak, Wojciech, Lener, Marcin R., Lubinski, Jan, Górski, Bohdan, Masojc, Bartoomiej, Kram, Andrzej, Maleszka, Romuald, Cybulski, Cezary, Paszkowska-Szczur, Katarzyna, Kashyap, Aniruddh, Murawa, Dawid

Intralesional PV-10 for the treatment of in-transit melanoma metastases - results of a prospective, non-randomized, single center study

- Read, Tavis A., Smith, Aaron, Thomas, Janine, David, Michael, Foote, Matthew, Wagels, Michael, Barbour, Andrew, Smithers, B. Mark